Immix Biopharma Inc. (IMMX:NASDAQ) soared at $2.12, a gain of 30.1%. On Thu, May 19, 2022, IMMX:NASDAQ touched a New 2-Week High of $1.63. The stock got featured on our News Catalysts scanner on Fri, May 20, 2022 at 01:50 PM in the 'BIOTECH' category. From Fri, May 06, 2022, the stock recorded 22.22% Up Days and 40.00% Green Days
The stock spiked on Mon, Jan 03, 2022 at $8.68 with a volume of 148M+.
About Immix Biopharma Inc. (IMMX:NASDAQ)
Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation.
Top 10 Gainers:
- Leju Holdings Limited (LEJU:NYSE), 53.38%
- NanoViricides, Inc. (NNVC:NYSEMKT), 40.54%
- Redbox Entertainment Inc. (RDBX:NASDAQ), 40%
- TherapeuticsMD, Inc. (TXMD:NASDAQ), 36.56%
- Esports Technologies Inc. (EBET:NASDAQ), 33.68%
- Immix Biopharma Inc. (IMMX:NASDAQ), 30.06%
- The Beachbody Company Inc. Class A (BODY:NYSE), 26.77%
- Dermira, Inc. (DERM:NASDAQ), 26.05%
- Allarity Therapeutics Inc. (ALLR:NASDAQ), 25%
- Lianluo Smart Limited (LLIT:NASDAQ), 24.59%